Haykin, Leah A.
Francke, Jordan A.
Abapali, Aurelia
Yakubu, Elliasu
Dambayi, Edith
Jackson, Elizabeth F.
Aborigo, Raymond
Awuni, Denis
Nonterah, Engelbert A.
Oduro, Abraham R.
Bawah, Ayaga A.
Phillips, James F.
Heller, David J.
Funding for this research was provided by:
Fogarty International Center (TW010452-01)
Teva Pharmaceutical Industries
Article History
Received: 23 August 2019
Accepted: 16 March 2020
First Online: 24 May 2020
Ethics approval and consent to participate
: The study design, consent forms, and data collection tools were approved by the Program for the Protection of Human Subjects at the Icahn School of Medicine at Mount Sinai; the Institutional Review Board of the Navrongo Health Research Centre; and the Human Research Protection Office at Columbia University. All NPHWs completed written informed consent forms prior to participating in the study. This included consent to publish participants’ anonymous quotes.
: No consent was requested, or given, for any other identifiers such as images, video, or other personal details, as we deemed these data not applicable to this study.
: The authors declare that they have no competing interests.